100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
10417-63-716α-Methyl Prednisolone
● In Stock
| Catalogue No.: | VE009512 |
|---|---|
| CAS No.: | 10417-63-7 |
| Mol. Formula: | C22H30O5 |
| Mol. Weight: | 374.47 g/mol |
Additional information on CAS 10417-63-7
Parent drug
PrednisoloneIUPAC Name
(8S, 9S, 10R, 11S, 13S, 14S, 16R, 17R)-11, 17-dihydroxy-17-(2-hydroxyacetyl)-10, 13, 16-trimethyl-6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17-dodecahydro-3H-cyclopenta[a]phenanthren-3-oneSynonyms
N/ADescription
16α-Methyl Prednisolone (CAS No: 10417-63-7) Or (8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-17-(2-hydroxyethyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one, 16α-Methyl Prednisolone is an impurity present in Prednisolone,Prednisone is a synthetic, anti-inflammatory glucocorticoid that derives from cortisone. delayed-release corticosteroid is indicated as an anti-inflammatory or immunosuppressive agent to treat a broad range of diseases, including immunosuppressive neoplastic, edematous, gastrointestinal, and acute exacerbations of multiple sclerosis, and as an anti-inflammatory and antineoplastic agent.References
Puckett, Y., Aishah Gabbar, & Bokhari, A. A. (2022, May 8). Prednisone. Retrieved June 16, 2022, from Nih.gov website: https://www.ncbi.nlm.nih.gov/books/NBK534809/Request a Quote
"*" indicates required fields
Other products related to Prednisolone impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
